Skip to main content
File #: 23-130    Version: 2 Name:
Type: Report Status: Agenda Ready
File created: 2/1/2023 In control: BOARD OF SUPERVISORS
On agenda: 2/7/2023 Final action:
Title: (a) Consideration of Presentation on Lake County Opioid Settlement Funds by Lake County Behavioral Health and Health Services Departments, (b) Approval to use a portion of funds towards the match for the Behavioral Health Continuum Infrastructure Program Round 6 and (c) Board and public feedback regarding proposed uses for funding.
Sponsors: Behavioral Health Services, Health Services
Attachments: 1. PRESENTATION_Lake Co. Opioid Settlement Fund_February 2023, 2. JD-OSF-Allowable-Expenses
Memorandum


Date: February 7, 2023

To: The Honorable Lake County Board of Supervisors

From: Todd Metcalf, Director Behavioral Health Services Department
Jonathan Portney, Director Health Services Department

Subject: (a) Consideration of Presentation on Lake County Opioid Settlement Funds by Lake County Behavioral Health and Health Services Departments, (b) Approval to use a portion of funds towards the match for the Behavioral Health Continuum Infrastructure Program Round 6 and (c) Board and public feedback regarding proposed uses for funding.

Executive Summary:

On July 21, 2021, a $26 billion offer to settle was made by opioid manufacturer Janssen Pharmaceuticals and the "big three" distributers: McKesson, AmerisourceBergen, and Cardinal Health. California will receive approximately $2.05 billion of this settlement over the next 18 years. The majority of this money is to be used for opioid abatement activities. Pursuant to Government Code, Title 2, Division 3, Part 2, Chapter 6, Article 2, Section 12534, the Opioid Settlements Fund (OSF) was created in the State Treasury. Funds from J&D settlement agreements and funds received from any other future judgments ?or settlements allocated to the state for state opioid remediation, shall be deposited into the OSF. Lake County received $897,310.78. Lake County will establish an advisory subcommittee through Health Service's SafeRx program and the SafeRx Coalition.


If not budgeted, fill in the blanks below only:
Estimated Cost: _N/A__ Amount Budgeted: __ N/A__ Additional Requested: _ N/A_ Future Annual Cost: _ N/A__

Purchasing Considerations (check all that apply): ? Not applicable
? Fully Article X.- and/or Consultant Selection Policy-Compliant (describe process undertaken in "Executive Summary")
? Section 2-38 Exemption from Competitive Bidding (rationale in "Executive Summary," attach documentation, as needed)
? For Technology Purchases: Vetted and Supported by the Technology Governance Committee ("Ye...

Click here for full text